Kalogeropoulos A.P.,Emory University |
Georgiopoulou V.V.,Emory University |
Murphy R.A.,U.S. National Institute on Aging |
Newman A.B.,University of Pittsburgh |
And 5 more authors.
JAMA Internal Medicine | Year: 2015
IMPORTANCE: Additional information is needed about the role of dietary sodium on health outcomes in older adults. OBJECTIVE: To examine the association between dietary sodium intake and mortality, incident cardiovascular disease (CVD), and incident heart failure (HF) in older adults. DESIGN, SETTING, AND PARTICIPANTS: We analyzed 10-year follow-up data from 2642 older adults (age range, 71-80 years) participating in a community-based, prospective cohort study (inception between April 1, 1997, and July 31, 1998). EXPOSURES: Dietary sodium intake at baseline was assessed by a food frequency questionnaire. We examined sodium intake as a continuous variable and as a categorical variable at the following levels: less than 1500 mg/d (291 participants [11.0%]), 1500 to 2300 mg/d (779 participants [29.5%]), and greater than 2300 mg/d (1572 participants [59.5%]). MAIN OUTCOMESAND MEASURES: Adjudicated death, incident CVD, and incident HF during 10 follow-up years. Analysis of incident CVD was restricted to 1981 participants without prevalent CVD at baseline. RESULTS: The mean (SD) age of participants was 73.6 (2.9) years, 51.2% were female, 61.7% were of white race, and 38.3% were black. After 10 years, 881 participants had died, 572 had developed CVD, and 398 had developed HF. In adjusted Cox proportional hazards regression models, sodium intake was not associated with mortality (hazard ratio [HR] per 1 g, 1.03; 95% CI, 0.98-1.09; P =.27). Ten-year mortality was nonsignificantly lower in the group receiving 1500 to 2300 mg/d (30.7%) than in the group receiving less than 1500 mg/d (33.8%) and the group receiving greater than 2300 mg/d (35.2%) (P =.07). Sodium intake of greater than 2300 mg/d was associated with nonsignificantly higher mortality in adjusted models (HR vs 1500-2300 mg/d, 1.15; 95% CI, 0.99-1.35; P =.07). Indexing sodium intake for caloric intake and body mass index did not materially affect the results. Adjusted HRs for mortality were 1.20 (95% CI, 0.93-1.54; P =.16) per milligram per kilocalorie and 1.11 (95% CI, 0.96-1.28; P =.17) per 100 mg/kg/m2 of daily sodium intake. In adjusted models accounting for the competing risk for death, sodium intake was not associated with risk for CVD (subHR per 1 g, 1.03; 95% CI, 0.95-1.11; P =.47) or HF (subHR per 1 g, 1.00; 95% CI, 0.92-1.08; P =.92). No consistent interactions with sex, race, or hypertensive status were observed for any outcome. CONCLUSIONS AND RELEVANCE: In older adults, food frequency questionnaire-assessed sodium intake was not associated with 10-year mortality, incident CVD, or incident HF, and consuming greater than 2300 mg/d of sodium was associated with nonsignificantly higher mortality in adjusted models. © 2015 American Medical Association. All rights reserved. Source
Murphy R.A.,U.S. National Institute on Aging |
Register T.C.,Sticht Center on Aging |
Shively C.A.,Section on Comparative Medicine Pathology |
Carr J.J.,Section on Radiologic science |
And 21 more authors.
Journals of Gerontology - Series A Biological Sciences and Medical Sciences | Year: 2014
Background. Knowledge of adipose composition in relation to mortality may help delineate inconsistent relationships between obesity and mortality in old age. We evaluated relationships between abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) density, mortality, biomarkers, and characteristics. Methods. VAT and SAT density were determined from computed tomography scans in persons aged 65 and older, Health ABC (n = 2,735) and AGES-Reykjavik (n = 5,131), and 24 nonhuman primates (NHPs). Associations between adipose density and mortality (4-13 years follow-up) were assessed with Cox proportional hazards models. In NHPs, adipose density was related to serum markers and tissue characteristics. Results .Higher density adipose tissue was associated with mortality in both studies with adjustment for risk factors including adipose area, total fat, and body mass index. In women, hazard ratio and 95% CI for the densest quintile (Q5) versus least dense (Q1) for VAT density were 1.95 (1.36-2.80; Health ABC) and 1.88 (1.31-2.69; AGES-Reykjavik) and for SAT density, 1.76 (1.35-2.28; Health ABC) and 1.56 (1.15-2.11; AGES-Reykjavik). In men, VAT density was associated with mortality in Health ABC, 1.52 (1.12-2.08), whereas SAT density was associated with mortality in both Health ABC, 1.58 (1.21-2.07), and AGES-Reykjavik, 1.43 (1.07-1.91). Higher density adipose tissue was associated with smaller adipocytes in NHPs. There were no consistent associations with inflammation in any group. Higher density adipose tissue was associated with lower serum leptin in Health ABC and NHPs, lower leptin mRNA expression in NHPs, and higher serum adiponectin in Health ABC and NHPs. Conclusion. VAT and SAT density provide a unique marker of mortality risk that does not appear to be inflammation related. © 2013 The Author. Source
Buford T.W.,University of Florida |
Church T.S.,Pennington Biomedical Research Center |
Gill T.M.,Yale University |
Henderson R.,Section on Gerontology and Geriatrics |
And 5 more authors.
Journals of Gerontology - Series A Biological Sciences and Medical Sciences | Year: 2016
Background: This subgroup analysis of the Lifestyle Intervention and Independence for Elders trial evaluates the impact of a long-term physical activity (PA) intervention on rates of major mobility disability (MMD) among older adults according to their antihypertensive medication use. Methods: Lifestyle Intervention and Independence for Elders study participants were randomized to center-based PA or health education for a median of 2.7 years. Participants were sedentary men and women aged 70-89 years with objectively measured physical limitations. This analysis evaluated rates of MMD and persistent MMD among 1, 633 participants, according to antihypertensive medication use. Participants were designated as either (i) an angiotensin-converting enzyme (ACE) inhibitor user (ACEi+), (ii) a user of other antihypertensives not including ACEi (ACEi-), or (iii) nonusers of antihypertensive medications (AHT-). Interactions were explored between antihypertensive use and randomized arm. Results: Interaction terms for MMD (p=.214) and persistent MMD (p=.180) did not reach statistical significance. For MMD, PA displayed marginal effects among ACEi+(hazard ratio [HR]=0.76; 95%confidence interval [CI]=0.57, 1.02) and ACEi- (HR=0.76; 95%CI=0.60, 0.97) but not AHT- (HR=1.19; 95%CI=0.75, 1.87). For persistent MMD, the effect of PA was greatest among ACEi+(HR=0.57; 95%CI=0.39, 0.84) when compared to ACEi- (HR=0.76; 95%CI=0.55, 1.06) or AHT- (HR=1.18; 95%CI=0.59, 2.36). Conclusions: The effects of long-term PA on the incidence of MMD and persistent MMD were similar among three subgroups of older adults stratified by their antihypertensive medication use. However, though statistical interactions did not reach significance, several findings may warrant future study in other cohorts given the post hoc nature of this study. © The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. Source
Tyrrell D.J.,Section on Gerontology and Geriatrics |
Bharadwaj M.S.,Section on Gerontology and Geriatrics |
Van Horn C.G.,Section on Gerontology and Geriatrics |
Marsh A.P.,Wake forest University |
And 2 more authors.
Experimental Gerontology | Year: 2015
Background: Physical function and strength decline with age and lead to limited mobility and independence in older adults. Alterations in mitochondrial function are thought to underlie numerous age-related changes, including declining physical ability. Recent studies suggest that systemic changes in bioenergetic capacity may be reported by analyzing mitochondrial function in circulating cells. The objective of this study was to determine whether the bioenergetic capacity of peripheral blood mononuclear cells (PBMCs) is related to differences in physical function among older, overweight/obese, adults. To address this, we tested the hypothesis that greater PBMC respirometric capacity would be associated with better physical function, muscular strength, leg lean mass, and muscle quality. Furthermore, we tested whether the respirometric capacity of PBMCs is related to cellular composition and inflammatory status reported by interleukin-6 (IL-6). Methods: Fasted PBMC respiration (pmol/min/500,000 cells), expanded short physical performance battery (Ex-SPPB), peak knee extensor (KE) strength (Nm), grip strength (kg), leg lean mass (kg, via dual energy X-ray absorptiometry [DXA]), muscle quality (Nm/kg), and plasma IL-6 (pg/mL) were analyzed in 15 well-functioning, community-dwelling, sedentary overweight/obese older men (n = 9) and women (n = 6) aged 65 to 78 (mean 68.3 ± 3.5 years). Pearson and partial correlations were calculated to determine associations between PBMC respiration and these variables. Results: Higher maximal respiration of PBMCs was associated with better Ex-SPPB (r = 0.58, p = 0.02), greater KE strength (r = 0.60, p = 0.02), greater grip strength (r = 0.52, p = 0.05) and lower IL-6 (r = -0.58, p = 0.04). Higher spare respiratory capacity was associated with better Ex-SPPB (r = 0.59, p = 0.02), greater KE strength (r = 0.60, p = 0.02), greater grip strength (r = 0.54, p = 0.04), greater leg muscle quality (r = 0.56, p = 0.04), and lower IL-6 (r = -0.55, p = 0.05). Monocyte and lymphocyte counts were not related to PBMC respiratory capacity. Conclusions: Our results indicate that respirometric profiles of readily obtainable blood cells are associated with physical function and strength. Future studies should be undertaken in order to determine whether blood-based bioenergetic profiling can provide an objective index of systemic mitochondrial health. © 2015 Elsevier Inc. Source